Experts find flaws in proposed Indian "Bayh-Dole" legislation
12 February 2010
Anju Ghangurde
Please Login to read the full article.
12 February 2010
Anju Ghangurde
An Indian bill, which encourages the commercialisation of intellectual property (IP) from government-financed R&D for the larger public good, is being widely debated, with some experts claiming that it is flawed and could stymie potential gains from the open source drug discovery model....
Please Login to read the full article.
RELATED CONTENT
NEWS
- Roche denies flouting Indian patent disclosure norms; so do Bayer, Pfizer
- Multinationals claim no flouting of Indian patent rules as disclosures come under scrutiny
- US Capitol Capsule: Obama gives tech transfer some love
- Panic! No, don't panic! ECJ embryonic stem cells ruling divides opinion
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
